An ageing population is driving demand for advanced therapeutics. The global market for head and neck cancer therapeutics is ...
A new trial finds that cetuximab outperforms durvalumab as a second-line treatment in patients who cannot tolerate cisplatin.
EXCLUSIVE: Comedian Rhod Gilbert's initial symptoms included a persistent cough and struggles with swallowing before a biopsy ...
TUESDAY, Nov. 26, 2024 (HealthDay News) -- Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but ...
With new data on petosemtamab set to be presented at the European Society for Medical Oncology Asia Congress, Merus believes ...
EXCLUSIVE: Comedian Rhod Gilbert discovered he had stage four head and neck cancer after suffering from a variety of symptoms ...
Head and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report.
A study found a common air pollutant in wildfire smoke, car exhaust, and industrial emissions increases the risk of certain ...
Rhod Gilbert has issued a warning to others after the everyday symptoms he was experiencing turned out to be stage four ...
Researchers have found that a glue ingredient, PVA, can make cancer treatments safer and more effective. When combined with a ...
Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same ingredient used in children's glue. Researchers found ...